The vertebrate neuromuscular junction (NMJ) is a large chemical synapse between motoneurons and skeletal muscle fibers, in which synaptic transmission is achieved through the action of neuronally released acetylcholine (ACh) and acetylcholine receptors (AChR) located in the postsynaptic membrane of muscle fibers. NMJs are experimentally easily accessible and thus have long been established as a model for synapse formation and development. Analysis of this peripheral synapse has helped to elucidate general principles of synaptogenesis (Sanes and Lichtman, 1999; Kummer et al., 2006; Witzemann, 2006; Wu et al., 2010) and contributed significantly to the understanding of muscular disorders such as congenital myasthenic syndromes (CMS), providing the basis to improve or develop therapeutic strategies (Engel, 2011). There are, however, many open questions about the nature of reciprocal signals that determine pre-and postsynaptic differentiation, including quantal size and size and shape of the postsynaptic architecture. These parameters reflect muscle-type-specific properties and display considerable variety comparing muscles throughout the animal kingdom (Slater, 2008) . What are the mechanisms that control the structural and functional rearrangements of synapses? There is general agreement that proper differentiation and maturation of the NMJ depend on the interaction of activity-dependent and activity-independent factors. It is not yet clear, however, how pre-and postsynaptic differentiation is coordinated to achieve precise endplate formation, nerve growth and location of synaptic activity. Genetic techniques and the growing number of genetically engineered mouse models 
Introduction
The vertebrate neuromuscular junction (NMJ) is a large chemical synapse between motoneurons and skeletal muscle fibers, in which synaptic transmission is achieved through the action of neuronally released acetylcholine (ACh) and acetylcholine receptors (AChR) located in the postsynaptic membrane of muscle fibers. NMJs are experimentally easily accessible and thus have long been established as a model for synapse formation and development. Analysis of this peripheral synapse has helped to elucidate general principles of synaptogenesis (Sanes and Lichtman, 1999; Kummer et al., 2006; Witzemann, 2006; Wu et al., 2010) and contributed significantly to the understanding of muscular disorders such as congenital myasthenic syndromes (CMS), providing the basis to improve or develop therapeutic strategies (Engel, 2011) . There are, however, many open questions about the nature of reciprocal signals that determine pre-and postsynaptic differentiation, including quantal size and size and shape of the postsynaptic architecture. These parameters reflect muscle-type-specific properties and display considerable variety comparing muscles throughout the animal kingdom (Slater, 2008) . What are the mechanisms that control the structural and functional rearrangements of synapses? There is general agreement that proper differentiation and maturation of the NMJ depend on the interaction of activity-dependent and activity-independent factors. It is not yet clear, however, how pre-and postsynaptic differentiation is coordinated to achieve precise endplate formation, nerve growth and location of synaptic activity. Genetic techniques and the growing number of genetically engineered mouse models 0925-4773/$ -see front matter Ó 2012 Elsevier Ireland Ltd. All rights reserved. http://dx.doi.org/10.1016/j.mod.2012.09.004 have extended our knowledge of synaptic components and the machinery that is required for assembly of the NMJ.
2.
Mouse models for the identification of synaptic regulators at the NMJ ''Knock-out'' (KO) mouse lines have demonstrated unequivocally that synaptic regulators including rapsyn, agrin, MuSK, as well as AChR, are essential for the formation of structurally and functionally intact NMJs. A selection of major regulators and the respective mouse lines ( Table 1) that have advanced our view on activity-dependent and activityindependent processes during synaptogenesis is presented in this brief review.
The receptor associated protein rapsyn (Frail et al., 1988 ) is a cytoskeletal protein that interacts stoichiometrically with AChR and localizes AChR/rapsyn clusters at the postsynaptic membrane (Froehner et al., 1990) . Mice lacking rapsyn die at birth, as they fail to concentrate AChR clusters at the developing NMJ and their nerves grow aberrantly (Gautam et al., 1995) .
The muscle-specific receptor tyrosine kinase, MuSK, was discovered to be specifically expressed in muscle where it localizes to the NMJ (Jennings et al., 1993; Valenzuela et al., 1995) . When MuSK is genetically inactivated NMJ do not form, motor nerves grow aberrantly and mice die shortly after birth (DeChiara et al., 1996) demonstrating that MuSK signaling is required for the so-called prepatterning of AChRs in prospective synaptic regions, which occurs prior to innervation. The postnatal conditional KO of MuSK (Hesser et al., 2006) demonstrates that deletion of MuSK in adult muscle leads to the degradation and complete loss of NMJs. MuSK is thus not only required for initial steps of synapse formation leading to the anchoring and clustering of AChRs but also for the stabilization and maintenance of endplates in postnatal life. This suggests that MuSK signaling may play distinct roles in the differentiation and maintenance of synapses.
Neuronally released agrin, isolated as AChR/acetylcholinesterase (AChE)-aggregating factor (Nitkin et al., 1987) contributes significantly to postsynaptic differentiation and stabilization of endplate receptors (Gautam et al., 1996) . In agrin-deficient mice the initially formed endplates cannot be maintained, nerve innervation is grossly abnormal, and embryos die at birth. Agrin binds to Lrp4 and thus activates MuSK (see below), which is essential for the stabilization of the early synaptic contacts. Agrin may, in addition, induce during later embryonic development new postsynaptic specializations .
The nicotinic AChRs, as central signal transducers on muscle, are composed of five homologous, membrane-spanning subunits (Raftery et al., 1980) . They are expressed in two forms that differ in subunit structure and physiological function. The embryonic-type AChRc consisting of a 2 bcd subunits predominates during embryonic development and is largely replaced in adult muscle by AChRe consisting of a 2 bed subunits (Mishina et al., 1986; Witzemann et al., 1987 Witzemann et al., , 1989 . The KO of c subunits and thus lack of embryonic-type AChRc causes premature death of mouse embryos shortly after birth (Takahashi et al., 2002; Liu et al., 2008) . Targeted disruption of the e subunit gene prevents the expression of adult-type AChRe, which severely impairs neuromuscular transmission. The mice die about 3 months after birth demonstrating that AChRe are essential for normal postnatal development of skeletal muscle Missias et al., 1997) .
Neurotransmission can be blocked pre-or postsynaptically. Inactivation of choline acetyltransferase (ChAT) prevents the synthesis of the neurotransmitter ACh (Misgeld et al., 2002; Brandon et al., 2003) . The complete lack of ACh in ChAT KO mice causes perinatal death and a dramatic increase in motor axon branching. The innervation territory is expanded and AChRs are densely packed in enlarged endplates. Munc18-1 is part of the vesicle release machinery that regulates the release of ACh (Heeroma et al., 2003) . The vesicular acetylcholine transporter (VAChT) mediates ACh storage by synaptic vesicles (de Castro et al., 2009 ). The KO of each protein causes a similar phenotype characterised by abnormal pre-and postsynaptic development.
In order to find out whether the presynaptically released regulator agrin is linked to ACh signaling, double KO mice were generated targeting the agrin and ChAT genes (Misgeld et al., 2005) preventing the expression of agrin and the synthesis of ACh. In spite of the lack of both neuronal signals synapse formation is partially rescued as endplates of normal size are formed. This suggests that ACh negatively regulates the formation of endplates presumably via the postsynaptic AChR. Further evidence has emerged that a cytoplasmic serine/threonine kinase Cdk5, plays a role in the ACh-mediated dispersion of AChR clusters (Lin et al., 2005; Fu et al., 2005) .
In mice deficient in AChR a1 subunits (classification of the muscle-specific a subunit) neurotransmission is interrupted postsynaptically. These mice fail to express embryonic AChRc on the postsynaptic side and die at birth . Similar as in ChAT KO mice lacking ACh, motor axon branching and innervation territory is increased. The results support the view that ACh regulates through postsynaptic AChRs endplate formation and synaptic growth negatively. Additional results suggest that ACh inhibits presynaptic specializations at the NMJ through interaction with nonpostsynaptic nicotinic AChRs (neuronal AChR comprised of five homomeric a7 subunits, transiently expressed in embryonic muscle) or muscarinic AChRs (predominantly localized to motor neurons or Schwann cells). A more detailed analysis of the respective receptors, however, is required to clarify the distinct molecular mechanisms that prevent the formation of presynaptic terminals not opposing a postsynaptic apparatus. Since ACh may actually interact with receptors located on motor neurons or Schwann cells it will be of interest to analyse not only the various nicotinic and muscarinic AChRs in developing NMJs but also the contribution of non-quantally released ACh as trophic factor (Vyskocil et al., 2009) . It should also be noted that yet-unknown retrograde signals from muscle to nerve might be implicated in the process of halting the growth and branching of innervating axons, and it is known that activity-dependent factors promote motoneuron death shortly before birth (Oppenheim et al., 2000; Banks et al., 2001; Terrado et al., 2001; Yampolsky et al., 2008) .
Rather surprising, however, were observations in mouse models with defective neural development. In mice lacking 
DNA topoisomerase IIb, motor axons fail to contact skeletal muscles (Yang et al., 2000) . In mice lacking the motoneuronspecifc transcription factor HB9 the phrenic nerve fails to form and the diaphragm muscle develops without innervation (Lin et al., 2001; Yang et al., 2001) . Despite absence of innervation of diaphragm or limb muscles, AChRs were clustered and concentrated in the central region of muscle fibers. This supports earlier observations of AChR clustering in embryos where nerve endings were damaged and inactivated by neurotoxins (Braithwaite and Harris, 1979) . Together these results then suggest that a nerve-independent mechanism regulates the prepatterning of AChR, which serves as a guide for the outgrowing motor nerves. In fact, live imaging experiments in zebrafish support the view that MuSK together with Wnt ligands cause the prepatterning of AChR (Jing et al., 2009 ). Additional regulatory proteins were identified by screening genomic DNAs from patients that suffer from limb girdle disease (Beeson et al., 2006 ) as well as searching for possible signaling molecules that bind to the cytoplasmic domain of MuSK (Okada et al., 2006) . This led to the discovery of the cytoplasmic adaptor protein (Dok-7) that activates MuSK. Dok-7 is required for both MuSK-mediated preclustering of AChRs and for agrin-stimulated AChR clustering upon innervation (Okada et al., 2006; Inoue et al., 2009) .
The low-density lipoprotein receptor-related protein Lrp4, identified by mutagenesis screens, is required for proper localization of MuSK and may act at the first step of assembly of the NMJ (Weatherbee et al., 2006) . In a simplified view, agrin released by motor neurons binds to Lrp4 expressed in muscle and activates MuSK (Kim et al., 2008; Zhang et al., 2008) . MuSK activation recruits Dok-7 and results in clustering and stabilization of essential postsynaptic proteins, including AChRs and the AChR-associated protein rapsyn. The major synaptic regulators are schematically presented in Fig. 1. 
3.
Activity-dependent and activityindependent mechanisms contribute to synapse formation Complex processes regulate the formation, maintenance, and plasticity of synapses that occur in multiple steps during early development and throughout postnatal life. The molecular signaling pathways that control on one hand relatively slow developmental changes (e.g. formation of synaptic contacts, conversion of embryonic to adult type receptors) and on the other side fast changes (response to denervation and changes in muscle activity) are still poorly understood and contributions of activity-dependent and activity-independent processes not clear. Postsynaptic endplate currents and synapse formation have been a central issue from early on and were studied by blocking synaptic transmission pharmacologically (Braithwaite and Harris, 1979) . Precise timing of interventions in these experiments is difficult and blockade of pre-or postsynaptic targets may be incomplete or lead to secondary effects. Rather than pharmacologically blocking essential synaptic regulators or deleting genes, one could either modulate their functional/structural properties or alter expression levels to learn more about specific contributions to synapse formation.
One strategy for selecting functionally crucial targets is to use insights gained from studies of neurological diseases such as CMS (Engel, 2011) . Null-mutations in the e subunit genes of human patients are not lethal but cause so-called slow-channel CMS . Mice lacking adult-type Motor nerve terminals contain synaptic vesicles, which store the neurotransmitter acetylcholine (ACh). ACh is synthesized by choline acetyltransferase (ChAT) and transported into vesicles by the vesicular acetyl choline transporter (VACht). Vesicles fuse with the presynaptic membrane to release ACh via the synaptic vesicle fusion protein complex interacting with munc18-1. ACh diffuses across the synaptic cleft and binds to postsynaptic acetylcholine receptors (AChRs). ACh binding induces the opening of ion channels and causes postsynaptic depolarization. Action potentials are initiated and propagated along the muscle membrane to stimulate muscle contraction. ACh disperses, in addition, AChRs that are not juxtaposed to nerve terminals, and antagonizes postsynaptic differentiation by mechanisms that are poorly understood. Rapsyn interacts in a stochiometric fashion with AChRs and is required for anchoring the AChR clusters in the postsynaptic membrane. The initial localization of AChR, the so-called prepatterning, occurs at specific regions, where synaptic contacts will be established. This requires, in addition to rapsyn, low-density lipoprotein receptorrelated protein 4 (Lrp4) and muscle-specific kinase (MuSK). MuSK interacts with another kinase, Dok-7, to activate signals that contribute to the anchoring and clustering of AChRs. Neuronally released agrin stabilizes postsynaptic differentiation by binding Lrp4 and activating MuSK but may also induce new postsynaptic specializations during embryonic development.
AChRe die prematurely since the residual embryonic AChRc cannot substitute for the missing receptors, as in humans. The mice serve, however, as SCCMS model since the long channel open times of the AChRc cause severe myasthenic symptoms. Mutations in the human c subunit are lethal or cause severe symptoms grouped under the term Escobar syndrome (Hoffmann et al., 2006; Morgan et al., 2006) . Mice lacking the embryonic AChRc show an abnormal embryonic development and die shortly after birth (Takahashi et al., 2002) . Targeted deletion of the AChRc and e subunits clearly demonstrate that the ion conductance properties of the endplate AChR regulate not only muscle function and physiology but have an impact on NMJ differentiation and maintenance.
The developmentally regulated conversion from embryonic AChRc to adult AChRe suggests a physiological role of receptor-mediated activity in synapse formation processes. It was assumed that the spontaneous contractile activity induced by AChRc promotes formation of the postsynaptic membrane specializations and is required for normal muscle development (Jaramillo et al., 1988) as well as myoblast fusion into myotubes (Entwistle et al., 1988) . What happens actually when adult-type AChRe are expressed instead of embryonictype AChRc during embryonic development, reducing channel open time and increasing ion conductance at synapses (Sakmann and Brenner, 1978; Herlitze et al., 1996) ? Mice that express via the c subunit gene genetically modified ''c/e'' subunits that mediate ''fast'' adult-type properties to the mutant AChRc/e answer this question (Koenen et al., 2005) . The adult homozygous mutant mice are indistinguishable from wild type littermates. However, the ''fast'' endplate currents during embryonic development increase nerve growth and cause a more spread out distribution of endplates in diaphragm muscle. This suggests that the ''slow'' AChRc-mediated endplate currents contribute significantly to the correct localization of synaptic contacts and ensure optimal innervation of skeletal muscle.
In order to distinguish between activity-dependent and activity-independent roles of ACh, mice were generated that express structurally intact but functionally silent AChRc/e-fc . The c subunit gene was modified in this case by integrating e subunit-specific DNA sequences carrying a mutation, P121L, that reduces the affinity for ACh as well as channel opening probability. The P121L mutation had been initially discovered in human patients to cause so-called fast-channel CMS . Homozygous mice expressing AChRc/e-fc channels during embryonic development die at birth. The lack of receptor-mediated activity leads to a series of pre-and postsynaptic aberrations, which are not rescued at late embryonic stages, when AChRc/e-fc are increasingly replaced by AChRe. A number of phenotypes of these embryos differ from the phenotypes of mice where ACh release is completely absent due to the absence of ChAT, VAChT, or a defective vesicular acetylcholine release machinery (Misgeld et al., 2002; Brandon et al., 2003; Heeroma et al., 2003; de Castro et al., 2009) . Particularly, endplate architecture, i.e., endplate size and distribution, and AChR density differ from what is reported for ChAT KO or wild type mice. Orderly innervation is completely disrupted and neurites lose all directionality covering the muscle in a latticework of axons. In contrast ChAT KO or VAChT KO animals, there is no sign of muscle fiber atrophy or degeneration suggesting that the presence of ACh, even if it does not trigger electrophysiological responses, is enough to prevent muscle degeneration. The AChRc/e-fc mice contain the complete machinery for synapse assembly with a single, clearly defined deficit, namely the absence of AChR-mediated postsynaptic activity. The AChRc/e-fc mice show that correct patterning of synaptic connections, prevention of multiple contacts and control of nerve growth require AChR-mediated activity. Besides the AChR-activity-dependent processes there is, in addition, a metabotropic, activity-independent contribution that limits AChR site density within an endplate, promotes nerve growth and formation of multiple endplates, and prevents muscle atrophy .
While the exploration of the role of ACh-evoked postsynaptic activity has benefitted from the various KO or double KO mouse models one should keep in mind the limitations inherent to this approach. Most importantly, these models cannot distinguish between phenotypes caused by the absence of synaptic transmission, and phenotypes arising from the disruption of molecular signaling pathways caused by the absence of crucial molecules such as ACh or AChR. This may lead to physiologically irrelevant alterations. Therefore, it is important to clearly define the effects of lack/change of preor postsynaptic activity in an otherwise intact synaptic environment using, e.g., mouse models, in which functional properties of synaptic regulators are selectively modulated.
Link between ACh/AChR and agrin/MuSK signaling
The number of synaptic regulators is continuously increasing (Wu et al., 2010) but it is still unclear how agrin/ Lrp4/MuSK signals are linked to ACh/AChR mediated signals. To address this issue MuSK signaling was modulated selectively making use of a frame shift and a missense mutation discovered in a human patient suffering from severe myasthenic syndromes (Chevessier et al., 2004) . The missense mutation in the cytoplasmic kinase domain impairs the interaction with Dok-7 (Okada et al., 2006) and thus MuSK activity. Hemizygous musk V789M/À mice carry, correspondingly, on one allele the missense mutation V789M in the MuSK kinase domain. On the other allele the kinase domain has been deleted to generate the genotype as discovered in the human patient. The musk V789M/À mice suffer from severe muscle weakness demonstrating that the mutations in the MuSK alleles are the cause of myasthenic syndromes. They represent not only a valuable model for studying the pathophysiology of MuSKinduced CMS but also the roles of MuSK for synapse formation, maturation and maintenance as well (Chevessier et al., 2008) . Surprisingly, the MuSK-dependent alterations of NMJ architecture are muscle-type-specific that result from muscle-specific differences in MuSK and AChR expression levels. These results suggest that MuSK activity and AChR expression is linked in a muscle-specific manner. The detailed analysis of MuSK and AChR expression in wild type and mutant mice will help clarify the molecular mechanisms by which MuSK and AChR signaling regulates the integrity of NMJs.
AChR function and stability at endplates
Embryonic NMJs are established and stabilized in a ''MuSK/ agrin'' and ''ACh/AChR''-dependent manner. Additional mechanisms are, however, required throughout life to maintain AChR concentrations, AChR subtype, density, endplate size, and subsynaptic architecture to control metabolic stabilities, and to adjust the functional and structural properties of the NMJs according to the physiological needs of the muscle. The complex, multifaceted, and temporally also overlapping processes that regulate channel conversion, stabilization of endplate AChRs, and differentiation of pre-and postsynaptic architecture (Sanes and Lichtman, 1999) still need clarification.
The prominent developmental ''c/e subunit switch'' (Mishina et al., 1986 ) is regulated by the differential transcription of the c and e subunit genes (Numberger et al., 1991; Witzemann et al., 1989) , respectively. The gating properties of endplate channels are changed with the switch and result in shorter endplate currents (Sakmann and Brenner, 1978) . Similar changes occur also in the CNS suggesting that ion channel conversion and speeding of synaptic currents could be an universal mechanism to specify innervation processes, as well as adaptations to changing physiological demands of neuronal circuits (Takahashi, 2005) . Could the expression of different AChR subtypes be regulated by neuronal signals as suggested previously (Brenner et al., 1990; Meier et al., 1998) and thereby determine AChR stability (Salpeter, 1999) ? A number of observations argue against a neuronal signal: The e subunit RNA and thus AChRe expression was not prevented by denervating developing muscles shortly after birth (Witzemann et al., 1989) , and the muscle-specific regulator MuSK induced the expression of e subunit mRNA (Sander et al., 2001) . Furthermore, the time course of channel conversion depends on the muscle type and even within the same muscle conversion is not synchronized but proceeds with great heterogeneity in a muscle fiber-specific manner Yampolsky et al., 2008) . This may be explained by the fact that primary myotubes form a framework for secondary myotubes added at later embryonic stages. These secondary myotubes are developmentally ''younger'' than myotubes formed earlier in development creating a ''developmental gradient'' among myotubes that makes them different in their gene expression status (Ontell and Kozeka, 1984) . AChR c-GFP/c-GFP mice express a green fluorescent embryonic-type AChRc -GFP (Yampolsky et al., 2008) and have been used to analyse channel conversion in detail. The c subunit gene transcription is strongly reduced in the AChR c-GFP/c-GFP mice. This has, however, no effect on the transcription of the other AChR subunits or postnatal development including innervation, but the ''c-GFP/e subunit RNA switch'' occurs 3-4 days earlier than in wild type mice. This result shows that the AChRc/AChRe conversion is not determined by neuronal signals. Comparing different endplates, it occurs endplatespecific in an unsynchronized, heterogeneous manner. Preexisting AChRc are not randomly replaced by newly inserted AChRe but in a directed fashion, starting from peripheral regions and progressing to the central parts of individual endplates (Yampolsky et al., 2008) . With a novel in vivo imaging method it is also possible to visualize individual endplates of a fast-twitch leg muscle and to follow channel conversion directly: complete channel conversion around postnatal day 3 proceeds in about 1 day . Furthermore one can follow the dynamics of channel conversion at high temporal resolution adding additional support to the view that the metabolic stabilities endplate AChRs are independent of receptor subtype and are regulated by an intrinsic muscle-specific maturation program . Regarding AChR stability, it is long known that AChRs in newly formed synapses turn over at rates of $1 day while in adult muscle the turnover rates are much slower and are in the order of more than 10 days. AChR stability depends critically on muscle activity since total pharmacological blockade of AChR or denervation destabilize AChRs and cause rapid turnover (Fambrough, 1979) . Denervation-induced destabilization can be completely prevented by electrical stimulation of the muscle (Akaaboune et al., 1999; Andreose et al., 1993; Brenner and Rudin, 1989) and there is evidence that stabilization is not a static integration process but results from AChR recycling (Akaaboune et al., 1999) .
AChR c-GFP/c-GFP mice depict, furthermore, the transient subcellular localization of embryonic AChR after denervation in high resolution (Yampolsky et al., 2010) and reveals that AChR integration/degradation depends largely on three parameters: the abundance of newly synthesized AChR, the actual receptor load of a given NMJ, and the synaptic stabilization of the receptors. In addition, it is assumed that the actin cytoskeleton is involved in regulating synaptic targeting and stabilization of AChRs. Recent experiments indicate that myoVa may contribute as a structural component to the stabilization AChRs at NMJ (Roder et al., 2008; Yampolsky et al., 2011) . The mechanism that localizes and stabilizes the AChRs within a postsynaptic scaffold, however, remains unknown. In summary, it is now clear that the developmentally regulated AChR channel conversion is regulated nerve-independent by a muscle-specific differentiation program and AChR subtype composition has no effect on the developmentally regulated stabilization endplate AChRs. The high resolution in vivo imaging method has great potential determining impaired AChR stability in live mouse models caused by synaptic dysfunction and could provide important insights into synaptogenesis as well as mechanisms of pathogenesis.
Outlook
Mouse models have provided new and unexpected insights in mechanisms that regulate synaptogenesis. The finding that neuronal signals are not required for initial postsynaptic specializations raises new questions of how muscle-derived and nerve-derived signals are organized to spatially restrict the nerve to form synapses at specific sites. Unexpected complexity in regulatory mechanisms is further reflected by the observation that ACh not only induces postsynaptic currents but regulates negatively synaptic growth by interacting with postsynaptic AChR as well as with nonsynaptic receptors. AChR-mediated activity controls muscle function but is also required for the correct patterning of synaptic connections, prevention of multiple contacts, and control of nerve growth. In addition, ''metabotropic'', activity-independent signals may affect endplate architecture and prevent muscle atrophy. The detailed analysis of agrin/ MuSK and ACh/AChR signaling will help clarify the molecular mechanisms that regulate formation and function of synapses in vivo.
